Skip to content

Clinical trials

Phase 3 Blood Coagulation Disorders trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Blood Coagulation Disorders Phase: Phase 3 Clear all

20 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20061
20081
20091
20111
20141
20162
20171
20183
20201
20232
20241
20252
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Recruiting3
Withdrawn3
Unknown status2
Active, not recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
BioMarin Pharmaceutical4
CSL Behring2
Genzyme, a Sanofi Company2
Kedrion S.p.A.2
Swedish Orphan Biovitrum2
Austin Health1
Baxalta now part of Shire1
Bayer1
Cangene Corporation1
Massachusetts General Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Blood Coagulation Disorders20
Hemophilia A12
Hematologic Diseases11
Hemorrhagic Disorders11
Coagulation Protein Disorders10
Blood Coagulation Disorders, Inherited7
Genetic Diseases, Inborn7
Hemostatic Disorders5
Genetic Diseases, X-Linked3
Hemophilia B3

Trials

Showing 26 to 20 of 20. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.